Reflect Scientific, Inc. (RSCF)
- Previous Close
0.0500 - Open
0.0525 - Bid --
- Ask --
- Day's Range
0.0500 - 0.0537 - 52 Week Range
0.0400 - 0.0700 - Volume
32,500 - Avg. Volume
66,719 - Market Cap (intraday)
4.283M - Beta (5Y Monthly) 1.88
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date Aug 11, 2025 - Aug 15, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Reflect Scientific, Inc., through its subsidiaries, engages in the design, development, and sale of scientific equipment for the life science and manufacturing industries worldwide. The company offers Cryometrix ultra-low temperature and blast freezers, which are used to store various products, including blood and cancer vaccines. It also provides laboratory consumables and disposables, such as filtration and purification products, customized sample handling vials, electronic wiring assemblies, high temperature silicone, and graphite and vespel/graphite sealing components for use by original equipment manufacturers in the field of gas/liquid chromatography in the chemical analysis industries. In addition, the company offers solvent chillers and refrigerated transportation products; and UV detectors and vial products. It serves hospitals, diagnostic laboratories, pharmaceutical and biotech companies, universities, governments, and private sector research facilities, as well as cold chain management, chemical, and industrial companies. The company was founded in 1999 and is based in Orem, Utah.
reflectscientific.comRecent News: RSCF
View MorePerformance Overview: RSCF
Trailing total returns as of 6/6/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RSCF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RSCF
View MoreValuation Measures
Market Cap
4.44M
Enterprise Value
3.61M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.58
Price/Book (mrq)
2.14
Enterprise Value/Revenue
2.10
Enterprise Value/EBITDA
407.48
Financial Highlights
Profitability and Income Statement
Profit Margin
-1.71%
Return on Assets (ttm)
-1.55%
Return on Equity (ttm)
-1.42%
Revenue (ttm)
1.72M
Net Income Avi to Common (ttm)
-29.42k
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
1.03M
Total Debt/Equity (mrq)
9.49%
Levered Free Cash Flow (ttm)
-262.37k